Transcription of HORMONE REPLACEMENT THERAPY - Medsafe
{{id}} {{{paragraph}}}
Example: bankruptcy
HORMONE REPLACEMENT THERAPY - Medsafe
HORMONE REPLACEMENT THERAPYT hese new key messages are based on recent research fi ndings on the risks associated with the use of Combined HORMONE REPLACEMENT THERAPY and Estrogen REPLACEMENT THERAPY . They replace the advice published by the NZGG in May KEY MESSAGESCOMBINED HRT (estrogen with progestogen): Combined HRT is not recommended for long-term use except in limited circumstances because the risks of breast cancer, venous thromboembolism (VTE), stroke and coronary heart disease (CHD) outweigh the benefi ts of fracture reduction and reduced risk of colorectal cancer. Combined HRT should not be used for the prevention or treatment of coronary heart disease or stroke.
HORMONE REPLACEMENT THERAPY These new key messages are based on recent research fi ndings on the risks associated with the use of Combined Hormone Replacement ...
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Practical Guide to Prescribing Hormone Replacement, Practical Guide to Prescribing Hormone Replacement Therapy, Antibiotic Dosing in Critically Ill, Crit-ically ill adult patients receiving, Replacement therapy, RENAL REPLACEMENT THERAPY IN CRITICAL CARE, Guide to Prescribing Nicotine Replacement Therapy, Deciding About Hormone Therapy Use, Global Consensus Statement on Menopausal Hormone, Global Consensus Statement on Menopausal Hormone Therapy, Argatroban for anticoagulation in continuous, Therapy